Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

About this Publication
Title
Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer.
Pubmed ID
40965868 (View this publication on the PubMed website)
Digital Object Identifier
Publication
JAMA Oncol. 2025 Sep 18
Authors
Meng Y, Wu F, Kwak S, Wang C, Usyk M, Freedman ND, Huang WY, Um CY, Gonda TA, Oberstein PE, Li H, Hayes RB, Ahn J
Affiliations
  • Department of Population Health, NYU Grossman School of Medicine, New York, New York.
  • Department of Microbiology, Albert Einstein College of Medicine, New York, New York.
  • Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland.
  • Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.
  • Department of Population Science, American Cancer Society, Atlanta, Georgia.
  • Department of Medicine, NYU Grossman School of Medicine, New York, New York.
  • NYU Laura and Isaac Perlmutter Cancer Center, New York, New York.
Abstract

IMPORTANCE: The oral microbiota may be involved in the development of pancreatic cancer, yet current evidence is largely limited to bacterial 16S amplicon sequencing and small retrospective case-control studies.

OBJECTIVE: To test whether the oral bacterial and fungal microbiome is associated with the subsequent development of pancreatic cancer.

DESIGN, SETTING, AND PARTICIPANTS: This cohort study used data from 2 epidemiological cohorts: the American Cancer Society Cancer Prevention Study-II Nutrition Cohort and the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Among cohort participants who provided oral samples, those who prospectively developed pancreatic cancer were identified during follow-up. Control participants who remained free of cancer were selected by 1:1 frequency matching on cohort, 5-year age band, sex, race and ethnicity, and time since oral sample collection. Data were collected from August 2023 to September 2024, and data were analyzed from August 2023 to January 2025.

EXPOSURES: The oral bacterial and fungal microbiome were characterized via whole-genome shotgun sequencing and internal transcribed spacer (ITS) sequencing, respectively. The association of periodontal pathogens of the red complex (Treponema denticola, Porphyromonas gingivalis, and Tannerella forsythia) and orange complex (Fusobacterium nucleatum, F periodonticum, Prevotella intermedia, P nigrescens, Parvimonas micra, Eubacterium nodatum, Campylobacter shower, and C gracilis) with pancreatic cancer was tested via logistic regression. The association of the microbiome-wide bacterial and fungal taxa with pancreatic cancer was assessed by Analysis of Compositions of Microbiomes With Bias Correction 2 (ANCOM-BC2). Microbial risk scores (MRS) for pancreatic cancer were calculated from the risk-associated bacterial and fungal species.

MAIN OUTCOMES AND MEASURES: Pancreatic cancer incidence.

RESULTS: Of 122 000 cohort participants who provided samples, 445 developed pancreatic cancer over a median (IQR) follow-up of 8.8 (4.9-13.4) years and were matched with 445 controls. Of these 890 participants, 474 (53.3%) were male, and the mean (SD) age was 67.2 (7.5) years. Three oral bacterial periodontal pathogens-P gingivalis, E nodatum, and P micra-were associated with increased risk of pancreatic cancer. A bacteriome-wide scan revealed 8 oral bacteria associated with decreased and 13 oral bacteria associated with increased risk of pancreatic cancer (false discovery rate-adjusted Q statistic less than .05). Of the fungi, genus Candida was associated with increased risk of pancreatic cancer. The MRS, based on 27 oral species, was associated with an increase in pancreatic cancer risk (multivariate odds ratio per 1-SD increase in MRS, 3.44; 95% CI, 2.63-4.51).

CONCLUSIONS AND RELEVANCE: In this cohort study, oral bacteria and fungi were significant risk factors for pancreatic cancer development. Oral microbiota hold promise as biomarkers to identify individuals at high risk of pancreatic cancer, potentially contributing to personalized prevention.

Related CDAS Studies
Related CDAS Projects